• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Theravance Biopharma Inc

+ Add to Watchlist

TBPH:US

14.9600 USD 0.1200 0.81%

As of 20:10:00 ET on 12/26/2014.

Snapshot for Theravance Biopharma Inc (TBPH)

Open: 14.9400 Day's Range: 14.7899 - 15.2400 Volume: 197,813
Previous Close: 14.8400 52wk Range: 13.1100 - 35.6750 1-Yr Rtn: -

Stock Chart for TBPH

No chart data available.
  • TBPH:US 14.9600
  • 1D
  • 1M
  • 1Y
14.8400
Interactive TBPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for TBPH

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -6.2600
Est. PEG Ratio -
Market Cap (M USD) 482.14
Shares Outstanding (M) 32.23
30 Day Average Volume 333,931
Price/Book (mrq) 1.4188
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/06/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for TBPH

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for TBPH

Theravance Biopharma Inc focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections, and central nervous system.

Rick E WinninghamPresident/CEO
More Company Profile & Key Executives for TBPH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil